Offer - Urjas Oil for just ₹ 1 X
Arip MT 5 Tablet (15) is a prescription drug, available for use as Tablet. Schizophrenia, Mania are some of its major therapeutic uses. Arip MT 5 Tablet (15) also has some secondary and off-label uses. These are listed below.
The right dosage of Arip MT 5 Tablet (15) depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Arip MT 5 Tablet (15) also has some side effects, the most common being Back Pain, Dizziness, Drowsiness. Apart from the aforementioned side effects, Arip MT 5 Tablet (15) can also lead to other problems, which have been listed below. Usually, these side effects of Arip MT 5 Tablet (15) go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Arip MT 5 Tablet (15) has a Moderate effect for pregnant women and Severe effect on lactating mothers. Further, the section on Arip MT 5 Tablet (15) related warnings talks about Arip MT 5 Tablet (15)'s effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Bradycardia (Slow Heart Rate), Tardive Dyskinesia, Dementia must refrain from the use of Arip MT 5 Tablet (15) since this can cause severe adverse effects. Some other conditions that can be affected by Arip MT 5 Tablet (15) are listed in the contraindications section below.
Drug reaction of Arip MT 5 Tablet (15) with other medicines has been reported. See below for a complete list.
You should also be aware that Arip MT 5 Tablet (15) is not safe while driving, and is not addiction.
Arip MT 5 Tablet (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Arip MT 5 Tablet (15) safe for pregnant women?
Arip Mt may have some side effects during pregnancy. Pregnant women should discontinue the use of Arip Mt, and talk to their doctor, if they notice any discomfort.
Is the use of Arip MT 5 Tablet (15) safe during breastfeeding?
Arip Mt should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Arip MT 5 Tablet (15) on the Kidneys?
Arip Mt is completely safe for kidneys.
What is the effect of Arip MT 5 Tablet (15) on the Liver?
Using Arip Mt does not have any harmful effects on the liver.
What is the effect of Arip MT 5 Tablet (15) on the Heart?
Arip Mt may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Arip MT 5 Tablet (15) unless your doctor advises you to do so -
Is this Arip MT 5 Tablet (15) habit forming or addictive?
Arip MT 5 Tablet (15) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Arip MT 5 Tablet (15) can make you feel drowsy.
Is it safe?
Yes, but take Arip MT 5 Tablet (15) only as per medical advice.
Is it able to treat mental disorders?
Yes, in many cases, taking Arip MT 5 Tablet (15) can help with mental disorders.
Interaction between Food and Arip MT 5 Tablet (15)
Some foods when eaten with Arip MT 5 Tablet (15) can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Arip MT 5 Tablet (15)
Taking alcohol with Arip MT 5 Tablet (15) can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Abilify® (aripiprazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 440,442
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 184-188